3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
18
Hematologic Neoplasms
14
Leukemia
13
Myelodysplastic Syndromes
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Hodgkin Disease
4
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Uterine Cervical Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Breast Neoplasms
2
Blast Crisis
2
Virus Diseases
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Thrombocytopenia
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Recurrence
1
Pyruvate Kinase Deficiency of Red Cells
1
Philadelphia Chromosome
1
Pathologic Complete Response
1
Interventions
posaconazole
1
liposomal amphotericin B
1
Fluconazole
1
Blood Specimen Collection
1
Amphotericin B
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Aspergillosis
×
Blood Specimen Collection
×
Other hematologic neoplasm
×
Clear all
NCT02955966
2025-11-20
OPTIFIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
51 enrolled